Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1183/13993003.00118-2025 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
It's "Blin" a Long Time Coming: The Rise of Blinatumomab in Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia.
Clin Lymphoma Myeloma Leuk
August 2025
Department of Clinical Pharmacy, Michigan Medicine and University of Michigan College of Pharmacy, Ann Arbor, MI. Electronic address:
Blinatumomab is a bispecific T-cell engager that has recently transformed front-line treatment for many patients with Philadelphia chromosome (Ph)-negative B-cell acute lymphoblastic leukemia (B-ALL). It was originally studied in relapsed/refractory disease, then moved to targeting measurable residual disease (MRD), and has since been shown to improve outcomes for almost every age group when added to consolidation chemotherapy. The evidence supporting blinatumomab is most robust in adult and standard-risk pediatric age groups, but its benefit in adolescents and young adults and high-risk pediatric patients is not yet understood.
View Article and Find Full Text PDFA Dual-Target Real-time PCR for proactive detection of Mpox variants.
J Virol Methods
September 2025
British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, British Columbia, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:
In 2022, cases of Monkeypox virus (MPXV) in California contained a mutation in the TNF receptor gene (GR2G) that rendered the virus undetectable using a widely adopted public health diagnostic qPCR assay. This underscored the need for a dual-target PCR approach and prompted validation of a second target by the BCCDC Public Health Laboratory. In addition to the GR2G target validated in the original qPCR assay (and duplexed with the endogenous target human β-globin (HBG)), GP113 (OPG128) was identified and validated using both clinical samples and MPXV DNA controls.
View Article and Find Full Text PDFMoving beyond the motor cortex: A brain-wide evaluation of target locations for intracranial speech neuroprostheses.
Cell Rep
September 2025
Department of Neurosurgery, Mental Health and Neuroscience Research Institute, Maastricht, the Netherlands. Electronic address:
Speech brain-computer interfaces (BCIs) offer a solution for those affected by speech impairments by decoding brain activity into speech. Current neuroprosthetics focus on the motor cortex, which might not be suitable for all patient populations. We investigate potential alternative targets for a speech BCI across a brain-wide distribution.
View Article and Find Full Text PDFNanomedicine Reimagined: Translational Strategies for Precision Tumor Theranostics.
Adv Mater
September 2025
Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.
Nanomedicine has shown remarkable promise in advancing tumor imaging and therapy through its ability to achieve targeted delivery, precision imaging, and therapeutic efficacy. However, translating these preclinical successes into clinical practice remains fraught with challenges, including inconsistent tumor targeting, off-target organ accumulation, and a lack of comprehensive understanding of in vivo behavior of nanomedicines. In this perspective, the current state of nanomedicine research is critically analyzed, emphasizing the translational bottlenecks and offering a forward-looking view on potential solutions.
View Article and Find Full Text PDFLeft Ventricular Motion Analysis Framework for the MATRIX-VT Study.
Int J Comput Assist Radiol Surg
September 2025
Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein, Ratzeburger Allee 160, Lübeck, 23652, Germany.
Purpose: Ultrasound (US) is commonly used to assess left ventricular motion for examination of heart function. In stereotactic arrhythmia radioablation (STAR) therapy, managing cardiorespiratory motion during radiation delivery requires representation of motion information in computed tomography (CT) coordinates. Similar to conventional US-guided navigation during surgical procedures, 3D US can provide real-time motion data of the radiation target that could be transferred to CT coordinates and then be accounted for by the radiation system.
View Article and Find Full Text PDF